Dr. Perrone and his team are at the forefront of PKD research, and we bring the latest treatments right to you. Currently, Drs. Perrone, Miskulin, and Gordon participate in clinical trials for patients with ADPKD including:
Bardoxolone (FALCON, Reata)
Our physicians and patients have also participated in the nation's most advanced clinical trials. Now completed trials that we participated in include: HALT PKD, Tempo 3/4, Reprise, Overture, Nocturne, tesevatinib (Kadmon), metformin (TAME), antimiR17 (Regulus), and venglustat (STAGED-PKD, Sanofi).
For more information, please email PKD@tuftsmedicine.org.
